Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Maher

Showing results (991-1000 of 1,158) with videos related to

Pageof 116
Sort By:
Respirology (Carlton, Vic.)|January 13, 2018
Pulmonary hypertension in interstitial lung disease: Limitations of echocardiography compared to cardiac catheterizationGregory J Keir, S John Wort, Maria Kokosi, et al.
Plos One|August 31, 2022
Under-screened Aboriginal and Torres Strait Islander women's perspectives on cervical screeningTamara L Butler, Natasha Lee, Kate Anderson, et al.
Mycoses|April 4, 2018
Isavuconazole for treatment of rare invasive fungal diseasesOliver A Cornely, Kathleen M Mullane, Luis Ostrosky-Zeichner, et al.
Hepatology (Baltimore, Md.)|August 3, 2007
Oxidative and electrophilic stress induces multidrug resistance-associated protein transporters via the nuclear factor-E2-related factor-2 transcriptional pathwayJonathan M Maher, Matthew Z Dieter, Lauren M Aleksunes, et al.
BMJ Open Respiratory Research|January 28, 2026
Prospective study of fibrosis in the lung endpoints (PROFILE): characteristics of an incident cohort of patients with idiopathic pulmonary fibrosisToby M Maher, Gisli R Jenkins, Gauri Saini, et al.
Clinical Science (London, England : 1979)|January 9, 2016
Epigenetic regulation of cyclooxygenase-2 by methylation of c8orf4 in pulmonary fibrosisIona C Evans, Josephine L Barnes, Ian M Garner, et al.
The European Respiratory Journal|July 2, 2021
Effects of nintedanib by inclusion criteria for progression of interstitial lung diseaseToby M Maher, Kevin K Brown, Michael Kreuter, et al.
Advances in Therapy|October 1, 2019
Modelling Forced Vital Capacity in Idiopathic Pulmonary Fibrosis: Optimising Trial DesignEva Santermans, Paul Ford, Michael Kreuter, et al.
Mycoses|April 4, 2018
Isavuconazole for treatment of invasive fungal diseases caused by more than one fungal speciesFrancisco M Marty, Oliver A Cornely, Kathleen M Mullane, et al.
Molecular Syndromology|January 29, 2021
A Case of UDP-Galactose 4'-Epimerase Deficiency Associated with Dyshematopoiesis and Atrioventricular Valve Malformations: An Exceptional Clinical Phenotype Explained by Altered N-Glycosylation with Relative Preservation of the Leloir PathwayChristopher A Febres-Aldana, Liset Pelaez, Meredith S Wright, et al.
Pageof 116

Showing results (991-1000 of 1,158) with videos related to

Sort By:
Pageof 116
Respirology (Carlton, Vic.)|January 13, 2018
Pulmonary hypertension in interstitial lung disease: Limitations of echocardiography compared to cardiac catheterizationGregory J Keir, S John Wort, Maria Kokosi, et al.
Plos One|August 31, 2022
Under-screened Aboriginal and Torres Strait Islander women's perspectives on cervical screeningTamara L Butler, Natasha Lee, Kate Anderson, et al.
Mycoses|April 4, 2018
Isavuconazole for treatment of rare invasive fungal diseasesOliver A Cornely, Kathleen M Mullane, Luis Ostrosky-Zeichner, et al.
Hepatology (Baltimore, Md.)|August 3, 2007
Oxidative and electrophilic stress induces multidrug resistance-associated protein transporters via the nuclear factor-E2-related factor-2 transcriptional pathwayJonathan M Maher, Matthew Z Dieter, Lauren M Aleksunes, et al.
BMJ Open Respiratory Research|January 28, 2026
Prospective study of fibrosis in the lung endpoints (PROFILE): characteristics of an incident cohort of patients with idiopathic pulmonary fibrosisToby M Maher, Gisli R Jenkins, Gauri Saini, et al.
Clinical Science (London, England : 1979)|January 9, 2016
Epigenetic regulation of cyclooxygenase-2 by methylation of c8orf4 in pulmonary fibrosisIona C Evans, Josephine L Barnes, Ian M Garner, et al.
The European Respiratory Journal|July 2, 2021
Effects of nintedanib by inclusion criteria for progression of interstitial lung diseaseToby M Maher, Kevin K Brown, Michael Kreuter, et al.
Advances in Therapy|October 1, 2019
Modelling Forced Vital Capacity in Idiopathic Pulmonary Fibrosis: Optimising Trial DesignEva Santermans, Paul Ford, Michael Kreuter, et al.
Mycoses|April 4, 2018
Isavuconazole for treatment of invasive fungal diseases caused by more than one fungal speciesFrancisco M Marty, Oliver A Cornely, Kathleen M Mullane, et al.
Molecular Syndromology|January 29, 2021
A Case of UDP-Galactose 4'-Epimerase Deficiency Associated with Dyshematopoiesis and Atrioventricular Valve Malformations: An Exceptional Clinical Phenotype Explained by Altered N-Glycosylation with Relative Preservation of the Leloir PathwayChristopher A Febres-Aldana, Liset Pelaez, Meredith S Wright, et al.
Pageof 116